Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 3—March 2007
Research

Matrix Protein 2 Vaccination and Protection against Influenza Viruses, Including Subtype H5N1

Stephen Mark Tompkins*1Comments to Author , Zi-Shan Zhao*, Chia-Yun Lo*, Julia A. Misplon*, Teresa Liu*, Zhiping Ye*, Robert J. Hogan†, Zhengqi Wu*, Kimberly A. Benton*, Terrence M. Tumpey‡, and Suzanne L. Epstein*
Author affiliations: *Food and Drug Administration, Bethesda, Maryland, USA; †University of Georgia, Athens, Georgia, USA; ‡Centers for Disease Control and Prevention, Atlanta, Georgia, USA;

Main Article

Figure 1

Results of matrix protein 2 (M2)e–keyhole limpet hemocyanin (KLH) vaccination, showing induction of cross-reactive antibody responses. Mice (7–9 per group) were immunized intraperitoneally with KLH or M2e peptides conjugated to KLH (M2e-con/KLH, M2e-FM/KLH, or M2e-H5(HK)/KLH) in complete Freund’s adjuvant. After 21 days, the mice were given an intraperitoneal booster with KLH or M2e-peptide/KLH in incomplete Freund’s adjuvant. Immune serum was collected 13 days after booster and assayed for immu

Figure 1. Results of matrix protein 2 (M2)e–keyhole limpet hemocyanin (KLH) vaccination, showing induction of cross-reactive antibody responses. Mice (7–9 per group) were immunized intraperitoneally with KLH or M2e peptides conjugated to KLH (M2e-con/KLH, M2e-FM/KLH, or M2e-H5(HK)/KLH) in complete Freund’s adjuvant. After 21 days, the mice were given an intraperitoneal booster with KLH or M2e-peptide/KLH in incomplete Freund’s adjuvant. Immune serum was collected 13 days after booster and assayed for immunoglobulin (Ig) G reactive to various M2e peptides by ELISA. Plates were coated with M2e-PR8 (panel A), M2e-FM (panel B), M2e-H5(SP-83) (panel C), or M2e-H5(HK) (panel D). Data are representative of multiple experiments. OD, optical density; e, ectodomain.

Main Article

1Current affiliation: University of Georgia, Athens, Georgia, USA

Page created: June 29, 2010
Page updated: June 29, 2010
Page reviewed: June 29, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external